title: Sildenafil prevents the increase of extravascular lung water and pulmonary hypertension after meconium aspiration in newborn piglets.
abstract: Meconium aspiration syndrome causes respiratory failure after birth and in vivo monitoring of pulmonary edema is difficult. The objective of the present study was to assess hemodynamic changes and edema measured by transcardiopulmonary thermodilution in low weight newborn piglets. Additionally, the effect of early administration of sildenafil (2 mg/kg vo, 30 min after meconium aspiration) on this critical parameter was determined in the meconium aspiration syndrome model. Thirty-eight mechanically ventilated anesthetized male piglets (Sus scrofa domestica) aged 12 to 72 h (1660 ± 192 g) received diluted fresh human meconium in the airway in order to evoke pulmonary hypertension (PHT). Extravascular lung water was measured in vivo with a PiCCO monitor and ex vivo by the gravimetric method, resulting in an overestimate of 3.5 ± 2.3 mL compared to the first measurement. A significant PHT of 15 Torr above basal pressure was observed, similar to that of severely affected humans, leading to an increase in ventilatory support. The vascular permeability index increased 57%, suggesting altered alveolocapillary membrane permeability. Histology revealed tissue vessel congestion and nonspecific chemical pneumonitis. A group of animals received sildenafil, which prevented the development of PHT and lung edema, as evaluated by in vivo monitoring. In summary, the transcardiopulmonary thermodilution method is a reliable tool for monitoring critical newborn changes, offering the opportunity to experimentally explore putative therapeutics in vivo. Sildenafil could be employed to prevent PHT and edema if used in the first stages of development of the disease.
authors.affiliation: Departmento de Neonatología, Área Básica, Hospital de Clínicas, Montevideo, Uraguay.
authors.forename: F E
authors.initials: FE
authors.lastname: Silvera
authors.forename: M F
authors.initials: MF
authors.lastname: Blasina
authors.forename: L
authors.initials: L
authors.lastname: Vaamonde
authors.forename: S
authors.initials: S
authors.lastname: Tellechea
authors.forename: C
authors.initials: C
authors.lastname: Godoy
authors.forename: S
authors.initials: S
authors.lastname: Zabala
authors.forename: G
authors.initials: G
authors.lastname: Mañana
authors.forename: M
authors.initials: M
authors.lastname: Martell
authors.forename: W
authors.initials: W
authors.lastname: Olivera
mesh_terms: D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D015633:Extravascular Lung Water / Q000187:drug effects*; D006801:Humans; D006976:Hypertension, Pulmonary / Q000517:prevention & control*; D007231:Infant, Newborn; D008168:Lung / Q000187:drug effects / Q000473:pathology; D008297:Male; D008471:Meconium Aspiration Syndrome / Q000188:drug therapy* / Q000473:pathology; D010879:Piperazines / Q000008:administration & dosage*; D011687:Purines / Q000008:administration & dosage; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000008:administration & dosage*; D034421:Sus scrofa; D013815:Thermodilution / Q000379:methods; D013997:Time Factors; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D010879:Piperazines; D011687:Purines; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate